Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted (not yet open) NIH opportunity for assay validation of high-quality cancer markers for clinical studies, offered under the UH2/UH3 phased mechanism with clinical trials not all…
- Deadline
- Not specified
- Posted
- Dec 8, 2025
- Award amount
- Amount not specified
In plain English
This is a forecasted (not yet open) NIH opportunity for assay validation of high-quality cancer markers for clinical studies, offered under the UH2/UH3 phased mechanism with clinical trials not allowed. As an NIH research announcement, it is aimed at research institutions and investigators rather than the general public. Eligibility details, award amounts, and deadlines have not been published yet. Interested research organizations should watch for the full announcement before the application window opens.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from National Institutes of Health — soonest deadline first.
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 3 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
National Institutes of Health · Up to $250K · Due in 8 days
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
National Institutes of Health · Amount varies · Due in 8 days
Also listed under National Institutes of Health.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.